ELAN Elanco Animal Health Inc
Price Chart
Executive Summary
Elanco's CEO Jeffrey Simmons and another senior executive made open-market purchases totaling $200K on May 15. In addition, eight directors received non-cash stock grants of 4,678 shares each on May 21 — a routine director compensation event with no economic outlay. The CEO/executive buys are the sole cash transactions and represent ~0.002% of Elanco's $10.9B market cap, a trivial amount with no material signal. Historical calibration on this ticker shows prior directional calls (score=8) produced a -18% T+5 return, while score=6 calls have only a 30% T+20 win rate — suggesting strong bullish scoring on this ticker has historically underperformed. With a 91% analyst buy rating, the insider purchases appear consistent with existing bull sentiment rather than new information.
Key Financial Metrics
Actionable Insight
CEO/executive purchases are positive but the dollar amount is trivial relative to Elanco's market cap. The buys align with the 91% bullish analyst consensus but do not signal material new information. Monitor for larger insider accumulation or the next 8-K earnings release for substantive catalysts.
Key Facts
- CEO Jeffrey Simmons purchased 5,000 shares for ~$100K on May 15
- Executive Modi Rajeev purchased 4,900 shares for ~$100K on May 15
- Total open-market purchases: $200K vs $10.9B market cap = ~0.002%
- Eight directors received identical non-cash grants of 4,678 shares each on May 21 (total $0 cash)
- Prior ELAN reports show score=6 filings have only 30% T+20 win rate; score=8 produced -18% T+5 return
Financial Impact
Two open-market buys totaling $200K, representing ~0.002% of $10.9B market cap — de minimis. Director grants are non-cash compensation with zero economic value.
Risk Factors
- Prior directional reads on ELAN have shown negative T+5 returns, indicating the stock may not react positively to modest insider signals
- The $200K total purchase is 0.002% of market cap — statistically noise; overstated reaction risk
- Director grants are routine compensation, not conviction buys
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ELAN-1779828423521 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 19, 2026
24d ago
|
Insider Cluster
| $23.61 $24.58 | ▲ +4.11% | ▲ +3.64% | $24.17 (+2.38%) |
|
May 19, 2026
24d ago
|
Insider Cluster
| $20.83 $23.69 | ▲ +13.74% | ▲ +12.50% | $24.17 (+16.05%) |
|
May 19, 2026
24d ago
|
Insider Cluster
| $20.83 $23.96 | ▲ +15.03% | ▲ +13.23% | $24.17 (+16.05%) |
|
May 6, 2026
5w ago
|
8-K
| $26.14 $21.43 | ▼ −18.01% | ▼ −19.14% | $24.17 (−7.53%) |
|
Apr 8, 2026
9w ago
|
DEFA14A
| $23.60 $23.21 | ▼ −1.65% | ▼ −5.17% | $24.17 (+2.43%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access